Cite Filings / SER / 0001708599-26-000005
Feed Companies Filings Check
Sign in
8-K

Current Report

Serina Therapeutics, Inc. · Filed 2026-01-28 · Acc 0001708599-26-000005

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , ser-20260127.htm

Around this filing

  • 2026-03-23 8-K Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  • 2026-02-03 4 Chief Scientific Officer sold 6,500 shares at $3.03 ($19,680)
  • 2026-01-30 S-3 Registration Statement
  • 2026-01-29 4 Chief Scientific Officer sold 6,500 shares at $3.57 ($23,186)
  • 2026-01-28 8-K Other events
  • 2026-01-23 4 Chief Scientific Officer sold 2,500 shares at $2.95 ($7,375)
  • 2026-01-15 8-K Delisting notice · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ser-20260127.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…